Thursday, February 04, 2016 11:28:50 AM
"Organization and Business
Discovery Minerals Ltd., (OTC PINKSHEETS: DSCR.PK) is an acquisition and development company
that targets natural resource properties through its wholly owned subsidiaries. These projects have
previously fallen within two categories of natural products, precious metals mining and industrial hemp
cultivation and processing. However, Discovery’s future interests and activities will be focused on the
marketing and distribution of Migranade, a naturopathic therapy for migraine headache sufferers, and the
development of several other homeopathic treatments for common human ailments in conjunction with
Doctor Charles Hensley. Dr. Hensley is best known for his groundbreaking treatment for the common
cold, Zicam, released to the market in the late 1990s. Discovery has an agreement in place to secure all
the technology underlying Migranade and the other treatments developed by Dr Hensley.
In addition, the Company is pursuing clean tech and alternative energy investments to be integrated into
these business channels."
DSCR
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM